Atom | PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Due Dates: September 5, 2024 | January 5, 2025 | April 5, 2025 | September 5, 2025

Funding Amounts: Phase I: up to $306,872 (6 months) | Phase II: up to $2,045,816 (2 years); higher budgets possible for select topics

Summary: Supports US small businesses in R&D projects aligned with NIH, CDC, and FDA missions; clinical trials are not allowed under this solicitation.

Key Information: Updated March 31, 2025 to align with agency priorities; review the full announcement before applying.

PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Sign in to see full grant listing